Thursday is the key date this week. ORCL and ADBE both report after the close on September 10. Oracle faces questions about cloud growth and AI infrastructure spending. Adobe must show AI monetisation is real across its creative tools. Also on Thursday, CPRT and RH report — giving investors two more reads on consumer health. Today, ABM holds its Q3 call and CASY reports after close.
NVDA sits at the centre of multiple stories simultaneously. An NVDA director filed $411 million in share sales between August 31 and September 2. Analysts still lifted their consensus target to $327.65. Yet options traders pushed put volume above call flow over the past week. Bears are hedging, even as the street stays bullish. Short interest remains just 1.2% of free float — the conviction is not in the shorts yet.
MU drew the heaviest negative options flow among large caps. It is up 256% year-to-date, making it a prime put target ahead of Q4 results. WOLF carries 74.9% of free float short — one of the most squeezed mid-caps in the US. PANW was downgraded and immediately attracted a rush into puts, with RSI sliding to 43.5.
CHWY short interest jumped 5 points in a week to 51.5% of free float. KNX saw shorts nearly double from 6% to 10.9% in the same period. MRNA carries 13.4% short interest — analyst upgrades there carry extra punch given that short overhang.
Bill Gates filed $927 million in RSG purchases. His stake in Republic Services now sits near 37%. That scale of buying is hard to ignore.
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
